Letters to the Editor

End-tidal CO2 monitoring – Reader Response

Share

In Response to: End-tidal CO2 monitoring

Dear Dr. Gelinas,

I am writing to applaud Donnelly Hellings et al. on their article, End-Tidal CO2 Monitoring. I support the authors’ stance that end-tidal CO2 (ETCO2) monitoring, although historically used in anesthetic procedures, has valuable implications for many clinical scenarios (Donnelly Hellings et al., 2024). The use of ETCO2 monitoring as an early indicator for ineffective respiration may avoid hypoxic events leading to intubation. The authors endorse continual CO2 readings as this will provide the practitioner with real-time data that aids in selecting medications, dosages, and treatments (Donnelly Hellings et al., 2024).

Pulse oximetry alone fails to detect ineffective ventilation as this is a multifaceted problem encompassing hypercapnia, hypoventilation, and hypoxemia. Respiratory depression, secondary to opioid administration, initially manifests as hypercapnia, which eventually leads to low pulse oximetry saturation (Khanna et al., 2020). In the critical care setting, practitioners favor spot-checking arterial blood gas samples to assess CO2 retention rather than continuous ETCO2 monitoring (Donnelly Hellings et al., 2024). In both scenarios, continuous ETCO2 would improve response time to patient deterioration and avoid adverse hypoxic events leading to endotracheal intubation.

The combination of both continuous capnography and pulse oximetry ought to be promoted in clinical settings such as emergency departments, infusion clinics, outpatient surgical centers, and post-anesthesia care units. Early detection and intervention of respiratory demise are key to optimal patient care. I want to extend my gratitude to the authors for their exceptional commitment to patient safety.

Sincerely,
Caroline Kahoun, BSN, RN, CCRN. DNP-CRNA Student
Mansfield, OH

Are you interested in sharing your input?
Please consider sending an electronic Letter to the Editor to share your opinion on American Nurse Journal content.

What are the guidelines for letter submissions?
Letters should be fewer than 275 words and take as their starting point an article published in American Nurse Journal in the past 2 months. Letters should be exclusive to American Nurse Journal and not submitted to or published in any other media. They must include the writer’s full name. Anonymous letters and letters written under pseudonyms will not be considered. Writers should disclose any personal or financial interest in the subject matter of their letters. Letters should not contain attachments.

Letters are screened prior to approval for posting; not all will be posted. We do not respond to requests for medical or legal advice. No material is intended to be a substitute for professional medical and legal advice.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.


cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

Which of the following is correct regarding pulse oximetry?

Recent Posts